| UniProt ID | TPD54_HUMAN | |
|---|---|---|
| UniProt AC | O43399 | |
| Protein Name | Tumor protein D54 | |
| Gene Name | TPD52L2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 206 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MDSAGQDINLNSPNKGLLSDSMTDVPVDTGVAARTPAVEGLTEAEEEELRAELTKVEEEIVTLRQVLAAKERHCGELKRRLGLSTLGELKQNLSRSWHDVQVSSAYVKTSEKLGEWNEKVTQSDLYKKTQETLSQAGQKTSAALSTVGSAISRKLGDMRNSATFKSFEDRVGTIKSKVVGDRENGSDNLPSSAGSGDKPLSDPAPF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDSAGQDI -------CCCCCCCC | 9.19 | 20068231 | |
| 1 | Sulfoxidation | -------MDSAGQDI -------CCCCCCCC | 9.19 | 28465586 | |
| 3 | Phosphorylation | -----MDSAGQDINL -----CCCCCCCCCC | 32.76 | 28355574 | |
| 12 | Phosphorylation | GQDINLNSPNKGLLS CCCCCCCCCCCCCCC | 32.77 | 29255136 | |
| 19 | Phosphorylation | SPNKGLLSDSMTDVP CCCCCCCCCCCCCCC | 32.45 | 29255136 | |
| 21 | Phosphorylation | NKGLLSDSMTDVPVD CCCCCCCCCCCCCCC | 21.87 | 29255136 | |
| 22 | Sulfoxidation | KGLLSDSMTDVPVDT CCCCCCCCCCCCCCC | 4.44 | 21406390 | |
| 23 | Phosphorylation | GLLSDSMTDVPVDTG CCCCCCCCCCCCCCC | 37.48 | 29255136 | |
| 29 | Phosphorylation | MTDVPVDTGVAARTP CCCCCCCCCHHCCCC | 33.51 | 22167270 | |
| 35 | Phosphorylation | DTGVAARTPAVEGLT CCCHHCCCCCCCCCC | 15.75 | 21815630 | |
| 42 | Phosphorylation | TPAVEGLTEAEEEEL CCCCCCCCHHHHHHH | 43.96 | - | |
| 50 | Methylation | EAEEEELRAELTKVE HHHHHHHHHHHHHHH | 29.33 | 115918789 | |
| 55 | Ubiquitination | ELRAELTKVEEEIVT HHHHHHHHHHHHHHH | 61.34 | 22053931 | |
| 55 (in isoform 2) | Ubiquitination | - | 61.34 | 21890473 | |
| 62 | Phosphorylation | KVEEEIVTLRQVLAA HHHHHHHHHHHHHHH | 23.14 | 30576742 | |
| 70 | Acetylation | LRQVLAAKERHCGEL HHHHHHHHHHHHHHH | 50.07 | 27452117 | |
| 70 | Succinylation | LRQVLAAKERHCGEL HHHHHHHHHHHHHHH | 50.07 | 23954790 | |
| 70 | Ubiquitination | LRQVLAAKERHCGEL HHHHHHHHHHHHHHH | 50.07 | - | |
| 71 (in isoform 6) | Phosphorylation | - | 42.82 | 25159151 | |
| 73 (in isoform 6) | Phosphorylation | - | 25.65 | 25159151 | |
| 78 | Acetylation | ERHCGELKRRLGLST HHHHHHHHHHHCCCH | 31.04 | 24847115 | |
| 80 (in isoform 6) | Phosphorylation | - | 31.36 | 20068231 | |
| 81 (in isoform 6) | Phosphorylation | - | 10.58 | 29507054 | |
| 83 (in isoform 6) | Phosphorylation | - | 4.12 | 20068231 | |
| 84 | Phosphorylation | LKRRLGLSTLGELKQ HHHHHCCCHHHHHHH | 21.56 | 20068231 | |
| 85 | Phosphorylation | KRRLGLSTLGELKQN HHHHCCCHHHHHHHH | 43.77 | 20068231 | |
| 90 | Ubiquitination | LSTLGELKQNLSRSW CCHHHHHHHHHCCCC | 32.60 | 21890473 | |
| 90 | Methylation | LSTLGELKQNLSRSW CCHHHHHHHHHCCCC | 32.60 | 72668545 | |
| 90 | Ubiquitination | LSTLGELKQNLSRSW CCHHHHHHHHHCCCC | 32.60 | 21890473 | |
| 90 (in isoform 1) | Ubiquitination | - | 32.60 | 21890473 | |
| 90 (in isoform 2) | Ubiquitination | - | 32.60 | 21890473 | |
| 90 (in isoform 3) | Ubiquitination | - | 32.60 | 21890473 | |
| 90 (in isoform 4) | Ubiquitination | - | 32.60 | 21890473 | |
| 91 (in isoform 6) | Phosphorylation | - | 69.58 | 25159151 | |
| 94 | Phosphorylation | GELKQNLSRSWHDVQ HHHHHHHCCCCCCHH | 31.64 | 23401153 | |
| 94 (in isoform 2) | Phosphorylation | - | 31.64 | 25159151 | |
| 94 (in isoform 3) | Phosphorylation | - | 31.64 | 25159151 | |
| 94 (in isoform 4) | Phosphorylation | - | 31.64 | 25159151 | |
| 96 | O-linked_Glycosylation | LKQNLSRSWHDVQVS HHHHHCCCCCCHHCC | 25.95 | 30059200 | |
| 96 | Phosphorylation | LKQNLSRSWHDVQVS HHHHHCCCCCCHHCC | 25.95 | 23927012 | |
| 96 (in isoform 2) | Phosphorylation | - | 25.95 | 25159151 | |
| 96 (in isoform 3) | Phosphorylation | - | 25.95 | 25159151 | |
| 96 (in isoform 4) | Phosphorylation | - | 25.95 | 25159151 | |
| 103 | O-linked_Glycosylation | SWHDVQVSSAYVKTS CCCCHHCCEEEEHHH | 7.67 | 30059200 | |
| 103 | Phosphorylation | SWHDVQVSSAYVKTS CCCCHHCCEEEEHHH | 7.67 | 21945579 | |
| 103 (in isoform 2) | Phosphorylation | - | 7.67 | 20068231 | |
| 103 (in isoform 3) | Phosphorylation | - | 7.67 | 20068231 | |
| 103 (in isoform 4) | Phosphorylation | - | 7.67 | 20068231 | |
| 104 | O-linked_Glycosylation | WHDVQVSSAYVKTSE CCCHHCCEEEEHHHH | 25.43 | 30059200 | |
| 104 | Phosphorylation | WHDVQVSSAYVKTSE CCCHHCCEEEEHHHH | 25.43 | 21945579 | |
| 104 (in isoform 2) | Phosphorylation | - | 25.43 | 29507054 | |
| 104 (in isoform 3) | Phosphorylation | - | 25.43 | 29507054 | |
| 104 (in isoform 4) | Phosphorylation | - | 25.43 | 29507054 | |
| 106 | Phosphorylation | DVQVSSAYVKTSEKL CHHCCEEEEHHHHHH | 12.39 | 21945579 | |
| 106 (in isoform 2) | Phosphorylation | - | 12.39 | 20068231 | |
| 106 (in isoform 3) | Phosphorylation | - | 12.39 | 20068231 | |
| 106 (in isoform 4) | Phosphorylation | - | 12.39 | 20068231 | |
| 108 | Ubiquitination | QVSSAYVKTSEKLGE HCCEEEEHHHHHHHH | 33.39 | 21890473 | |
| 108 (in isoform 1) | Ubiquitination | - | 33.39 | 21890473 | |
| 108 (in isoform 2) | Ubiquitination | - | 33.39 | 21890473 | |
| 108 (in isoform 3) | Ubiquitination | - | 33.39 | 21890473 | |
| 108 | Ubiquitination | QVSSAYVKTSEKLGE HCCEEEEHHHHHHHH | 33.39 | 21890473 | |
| 108 | Ubiquitination | QVSSAYVKTSEKLGE HCCEEEEHHHHHHHH | 33.39 | 21890473 | |
| 112 | Ubiquitination | AYVKTSEKLGEWNEK EEEHHHHHHHHHCHH | 62.65 | 21906983 | |
| 112 (in isoform 1) | Ubiquitination | - | 62.65 | 21890473 | |
| 114 (in isoform 2) | Phosphorylation | - | 49.28 | 25159151 | |
| 114 (in isoform 3) | Phosphorylation | - | 49.28 | 25159151 | |
| 114 (in isoform 4) | Phosphorylation | - | 49.28 | 25159151 | |
| 119 | Acetylation | KLGEWNEKVTQSDLY HHHHHCHHCCHHHHH | 47.58 | 27452117 | |
| 119 | Ubiquitination | KLGEWNEKVTQSDLY HHHHHCHHCCHHHHH | 47.58 | - | |
| 119 (in isoform 2) | Ubiquitination | - | 47.58 | 21890473 | |
| 119 (in isoform 3) | Ubiquitination | - | 47.58 | 21890473 | |
| 119 (in isoform 5) | Ubiquitination | - | 47.58 | 20972266 | |
| 121 | O-linked_Glycosylation | GEWNEKVTQSDLYKK HHHCHHCCHHHHHHH | 33.16 | 30059200 | |
| 123 | Phosphorylation | WNEKVTQSDLYKKTQ HCHHCCHHHHHHHHH | 21.88 | 28152594 | |
| 126 | Phosphorylation | KVTQSDLYKKTQETL HCCHHHHHHHHHHHH | 18.54 | 25394399 | |
| 127 | Acetylation | VTQSDLYKKTQETLS CCHHHHHHHHHHHHH | 57.55 | 27452117 | |
| 127 | Succinylation | VTQSDLYKKTQETLS CCHHHHHHHHHHHHH | 57.55 | 23954790 | |
| 128 | Ubiquitination | TQSDLYKKTQETLSQ CHHHHHHHHHHHHHH | 41.71 | 21906983 | |
| 128 (in isoform 1) | Ubiquitination | - | 41.71 | 21890473 | |
| 129 | Phosphorylation | QSDLYKKTQETLSQA HHHHHHHHHHHHHHH | 27.73 | - | |
| 132 | Phosphorylation | LYKKTQETLSQAGQK HHHHHHHHHHHHHHH | 23.15 | 29396449 | |
| 134 | O-linked_Glycosylation | KKTQETLSQAGQKTS HHHHHHHHHHHHHHH | 25.96 | 30059200 | |
| 134 | Phosphorylation | KKTQETLSQAGQKTS HHHHHHHHHHHHHHH | 25.96 | 25159151 | |
| 139 | Ubiquitination | TLSQAGQKTSAALST HHHHHHHHHHHHHHH | 43.46 | 20972266 | |
| 139 (in isoform 1) | Ubiquitination | - | 43.46 | 21890473 | |
| 140 | Phosphorylation | LSQAGQKTSAALSTV HHHHHHHHHHHHHHH | 18.73 | 29396449 | |
| 141 | Phosphorylation | SQAGQKTSAALSTVG HHHHHHHHHHHHHHH | 20.69 | 20068231 | |
| 144 (in isoform 3) | Phosphorylation | - | 4.39 | 24117733 | |
| 145 | O-linked_Glycosylation | QKTSAALSTVGSAIS HHHHHHHHHHHHHHH | 19.13 | OGP | |
| 145 | Phosphorylation | QKTSAALSTVGSAIS HHHHHHHHHHHHHHH | 19.13 | 25159151 | |
| 146 | O-linked_Glycosylation | KTSAALSTVGSAISR HHHHHHHHHHHHHHH | 29.72 | OGP | |
| 146 | Phosphorylation | KTSAALSTVGSAISR HHHHHHHHHHHHHHH | 29.72 | 25159151 | |
| 146 (in isoform 3) | Phosphorylation | - | 29.72 | 24117733 | |
| 146 (in isoform 4) | Phosphorylation | - | 29.72 | 25849741 | |
| 148 (in isoform 3) | Phosphorylation | - | 16.08 | 24117733 | |
| 148 (in isoform 4) | Phosphorylation | - | 16.08 | 25849741 | |
| 149 | O-linked_Glycosylation | AALSTVGSAISRKLG HHHHHHHHHHHHHHH | 20.35 | OGP | |
| 149 | Phosphorylation | AALSTVGSAISRKLG HHHHHHHHHHHHHHH | 20.35 | 25159151 | |
| 149 (in isoform 3) | Phosphorylation | - | 20.35 | 24117733 | |
| 151 (in isoform 3) | Phosphorylation | - | 4.36 | 24117733 | |
| 152 | O-linked_Glycosylation | STVGSAISRKLGDMR HHHHHHHHHHHHCCC | 24.07 | OGP | |
| 152 | Phosphorylation | STVGSAISRKLGDMR HHHHHHHHHHHHCCC | 24.07 | 23401153 | |
| 155 (in isoform 3) | Phosphorylation | - | 7.36 | 24275569 | |
| 155 (in isoform 4) | Phosphorylation | - | 7.36 | 27762562 | |
| 157 (in isoform 3) | Phosphorylation | - | 43.22 | 27135362 | |
| 157 (in isoform 4) | Phosphorylation | - | 43.22 | 25849741 | |
| 160 (in isoform 4) | Phosphorylation | - | 29.38 | 25849741 | |
| 161 | Phosphorylation | KLGDMRNSATFKSFE HHHCCCCCCCHHCHH | 20.51 | 22167270 | |
| 163 | Phosphorylation | GDMRNSATFKSFEDR HCCCCCCCHHCHHHH | 31.27 | 29255136 | |
| 164 (in isoform 3) | Phosphorylation | - | 6.62 | 27762562 | |
| 164 (in isoform 7) | Phosphorylation | - | 6.62 | 24117733 | |
| 165 | Acetylation | MRNSATFKSFEDRVG CCCCCCHHCHHHHHC | 50.29 | 25953088 | |
| 165 | Methylation | MRNSATFKSFEDRVG CCCCCCHHCHHHHHC | 50.29 | 90159 | |
| 165 | Ubiquitination | MRNSATFKSFEDRVG CCCCCCHHCHHHHHC | 50.29 | - | |
| 166 | Phosphorylation | RNSATFKSFEDRVGT CCCCCHHCHHHHHCC | 29.67 | 29255136 | |
| 166 (in isoform 3) | Phosphorylation | - | 29.67 | 25849741 | |
| 166 (in isoform 5) | Phosphorylation | - | 29.67 | 25849741 | |
| 168 (in isoform 5) | Phosphorylation | - | 52.58 | 25849741 | |
| 169 (in isoform 3) | Phosphorylation | - | 48.86 | 25849741 | |
| 169 (in isoform 7) | Phosphorylation | - | 48.86 | 24117733 | |
| 170 | Methylation | TFKSFEDRVGTIKSK CHHCHHHHHCCCEEE | 22.90 | 115918785 | |
| 171 (in isoform 7) | Phosphorylation | - | 14.18 | 24117733 | |
| 173 | Phosphorylation | SFEDRVGTIKSKVVG CHHHHHCCCEEEECC | 23.52 | 28355574 | |
| 175 (in isoform 5) | Phosphorylation | - | 44.02 | 27762562 | |
| 176 | Phosphorylation | DRVGTIKSKVVGDRE HHHCCCEEEECCCCC | 27.17 | 21601212 | |
| 177 (in isoform 5) | Phosphorylation | - | 35.62 | 25849741 | |
| 180 (in isoform 5) | Phosphorylation | - | 31.11 | 25849741 | |
| 184 (in isoform 7) | Phosphorylation | - | 57.04 | 27762562 | |
| 186 | Phosphorylation | VGDRENGSDNLPSSA CCCCCCCCCCCCCCC | 34.60 | 25849741 | |
| 191 | Phosphorylation | NGSDNLPSSAGSGDK CCCCCCCCCCCCCCC | 35.67 | 23401153 | |
| 192 | Phosphorylation | GSDNLPSSAGSGDKP CCCCCCCCCCCCCCC | 34.41 | 25159151 | |
| 195 | Phosphorylation | NLPSSAGSGDKPLSD CCCCCCCCCCCCCCC | 43.46 | 25159151 | |
| 198 | Ubiquitination | SSAGSGDKPLSDPAP CCCCCCCCCCCCCCC | 51.92 | - | |
| 201 | Phosphorylation | GSGDKPLSDPAPF-- CCCCCCCCCCCCC-- | 50.50 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TPD54_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TPD54_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TPD54_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-12, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-96; SER-149 AND SER-166,AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-12, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-12; SER-21;SER-96 AND SER-166, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-166, AND MASSSPECTROMETRY. | |
| "Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161; SER-166 ANDTHR-173, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-96 AND SER-166,AND MASS SPECTROMETRY. | |